Detailed Information on Publication Record
2022
Efficacy and safety of novel temperature-controlled radiofrequency ablation system during pulmonary vein isolation in patients with paroxysmal atrial fibrillation: TRAC-AF study
STÁREK, Zdeněk, František LEHAR, Jiří JEŽ, Martin PEŠL, Petr NEUZIL et. al.Basic information
Original name
Efficacy and safety of novel temperature-controlled radiofrequency ablation system during pulmonary vein isolation in patients with paroxysmal atrial fibrillation: TRAC-AF study
Authors
STÁREK, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), František LEHAR (203 Czech Republic, belonging to the institution), Jiří JEŽ (203 Czech Republic, belonging to the institution), Martin PEŠL (203 Czech Republic, belonging to the institution), Petr NEUZIL (203 Czech Republic), Lucie SEDIVA (203 Czech Republic), Jan PETRU (203 Czech Republic), Libor DUJKA (203 Czech Republic), Moritoshi FUNASAKO, Josef KAUTZNER (203 Czech Republic), Petr PEICHL (203 Czech Republic), Bashar ALDHOON, Jean-Paul ALBENQUE, Stephane COMBES, Serge BOVEDA, Srinivas R. DUKKIPATI and Vivek Y. REDDY
Edition
Journal of interventional cardiac electrophysiology, Dordrecht, Springer, 2022, 1383-875X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.800
RIV identification code
RIV/00216224:14110/22:00124969
Organization unit
Faculty of Medicine
UT WoS
000658058700001
Keywords in English
Catheter radiofrequency ablation; Atrial fibrillation; Diamond tip irrigated catheter; Temperature contol ablation; High-resolution electrograms; Safety and efficacy
Tags
International impact, Reviewed
Změněno: 16/1/2023 12:17, Mgr. Tereza Miškechová
Abstract
V originále
Background and purpose Saline-irrigated radiofrequency ablation (RFA) for atrial fibrillation (AF) is limited by the absence of reliable thermal feedback limiting the utility of temperature monitoring for power titration. The DiamondTemp (DT) ablation catheter was designed to allow efficient temperature-controlled irrigated ablation. We sought to assess the 1-year clinical safety and efficacy of the DT catheter in treating drug-refractory paroxysmal AF. Methods The TRAC-AF trial (NCT02821351) is a prospective, multi-center (n = 4), single-arm study which enrolled patients with symptomatic, drug-refractory, paroxysmal AF. Using the DT catheter, point-by-point ablation was performed around all pulmonary veins (PVs) to achieve PV isolation (PVI). Ablation was performed in a temperature-controlled mode (60 degrees C, max 50 W). Acute and chronic efficacy and safety was evaluated. Results Seventy-one patients (age 69.9 +/- 11.0 years; 60.6% male) were ablated using the DT catheter. The mean fluoroscopy and RF ablation times were 9.3 +/- 6.1 min and 20.6 +/- 8.9 min, respectively. Acute isolation of all PVs was achieved in 100% of patients, and freedom from AF after 1 year was 70.6%. There were no steam pops, char, or coagulum on the catheter tip after ablation. There were few serious procedure/device-related adverse events including a single case of cardiac tamponade (1.4%) and transient ischemic attack (1.4). Conclusion This first inman series demonstrates that temperature-controlled irrigated RFA with the DT catheter is efficient, safe, and effective in the treatment of paroxysmal AF. Randomized controlled trials are ongoing and will evaluate better the role of this catheter in relation to standard RFA.